National Health Investors, Inc. (NHI) trades at a trailing P/E of 28.2, forward P/E of 26.0. Trailing earnings yield is 3.54%, forward earnings yield 3.84%. PEG 3.03. Graham Number is $47.35.
Criteria proven by this page:
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 19.1 | -9.45 | 2.39 | 11.64 | 4.78% |
| 2017 | 19.3 | 37.53 | 2.33 | 11.06 | 4.96% |
| 2018 | 20.5 | -3.64 | 2.28 | 10.75 | 5.22% |
| 2019 | 22.0 | -0.63 | 2.36 | 11.12 | 5.08% |
| 2020 | 16.7 | 0.64 | 2.04 | 9.29 | 6.29% |
| 2021 | 23.5 | -0.43 | 1.74 | 8.79 | 6.96% |
| 2022 | 35.2 | -0.57 | 1.84 | 8.40 | 6.92% |
| 2023 | 17.9 | 0.04 | 1.93 | 7.58 | 6.45% |
| 2024 | 22.0 | 68.92 | 2.22 | 9.07 | 5.15% |
| 2025 | 25.2 | -7.19 | 2.35 | 9.46 | 4.74% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $3.87 | $248.5M | $151.54M | 61% |
| 2017 | $3.87 | $278.66M | $159.37M | 57.2% |
| 2018 | $3.67 | $294.61M | $154.33M | 52.4% |
| 2019 | $2.38 | $318.08M | $104.16M | 32.7% |
| 2020 | $3.03 | $332.81M | $135.37M | 40.7% |
| 2021 | $1.36 | $298.72M | $62.19M | 20.8% |
| 2022 | $0.51 | $278.19M | $23.06M | 8.3% |
| 2023 | $3.13 | $319.84M | $135.65M | 42.4% |
| 2024 | $3.13 | $335.18M | $137.99M | 41.2% |
| 2025 | $3.02 | $378.53M | $142.18M | 37.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $3.28 | $3.25 – $3.31 | $280.62M | $267.23M – $292.14M | 3 |
| 2027 | $3.53 | $3.47 – $3.59 | $323.25M | $307.83M – $336.52M | 3 |
| 2028 | $3.61 | $3.39 – $3.80 | $301.57M | $287.18M – $313.95M | 1 |
| 2029 | $0.00 | $0.00 – $0.00 | $303.8M | $289.31M – $316.28M | 0 |
| 2030 | $0.00 | $0.00 – $0.00 | $308.01M | $293.32M – $320.66M | 0 |
